GSK shares rose to the top of the FTSE 100 leader board after the drugmaker raised its 2025 guidance on the back of a strong third-quarter performance. The earnings were the last to be presented by ...

GSK plc GSK reported third-quarter 2025 core earnings of $1.48 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.26. Core earnings increased 11% year over year on a ...

GSK Plc raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s ...

Investors with a lot of money to spend have taken a bearish stance on GSK (NYSE:GSK). And retail traders should know. We noticed this today when the positions showed up on publicly available options ...

GSK PLC GSK shares rose 1.77% to £17.83 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.04% to 9,760.06. GSK PLC hit a ...

Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the August 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options chain for ...

Emma Walmsley will step down as chief executive of GSK (GSK) at the end of this year, but she will be going out on a high ...

FTSE 100 outperforms Europe as Next raises profit guidance and GSK lifts earnings forecast. Copper miners surge on record ...

Wave Life Sciences Ltd. (NASDAQ:WVE) stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.

The negative readout led to a collapse in share price for Alector, which now plans to cut almost half of its workforce while ...

GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a ...